litlas
ログインアカウント作成

Jonathan D. Licht

1990–2025 年に発表

135
論文数
27,080
被引用数
87
h 指数
131
i10 指数

被引用数

Jonathan D. Licht の年別被引用数1966 年: 被引用 1 件1991 年: 被引用 15 件1992 年: 被引用 9 件1993 年: 被引用 10 件1994 年: 被引用 17 件1995 年: 被引用 28 件1996 年: 被引用 29 件1997 年: 被引用 65 件1998 年: 被引用 94 件1999 年: 被引用 159 件2000 年: 被引用 167 件2001 年: 被引用 155 件2002 年: 被引用 156 件2003 年: 被引用 175 件2004 年: 被引用 200 件2005 年: 被引用 220 件2006 年: 被引用 173 件2007 年: 被引用 192 件2008 年: 被引用 165 件2009 年: 被引用 209 件2010 年: 被引用 250 件2011 年: 被引用 333 件2012 年: 被引用 347 件2013 年: 被引用 345 件2014 年: 被引用 383 件2015 年: 被引用 348 件2016 年: 被引用 335 件2017 年: 被引用 308 件2018 年: 被引用 291 件2019 年: 被引用 854 件2020 年: 被引用 917 件2021 年: 被引用 906 件2022 年: 被引用 723 件2023 年: 被引用 501 件2024 年: 被引用 774 件2025 年: 被引用 380 件2026 年: 被引用 7 件1967〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,402 件、この内訳の 33.8%中国: 引用元論文 1,528 件、この内訳の 11.8%ドイツ: 引用元論文 881 件、この内訳の 6.8%イギリス: 引用元論文 766 件、この内訳の 5.9%イタリア: 引用元論文 537 件、この内訳の 4.1%カナダ: 引用元論文 523 件、この内訳の 4%フランス: 引用元論文 499 件、この内訳の 3.8%日本: 引用元論文 403 件、この内訳の 3.1%オーストラリア: 引用元論文 290 件、この内訳の 2.2%オランダ: 引用元論文 288 件、この内訳の 2.2%スペイン: 引用元論文 273 件、この内訳の 2.1%スイス: 引用元論文 221 件、この内訳の 1.7%
0%33.8%その他 18.5%

機関

分野

  • Biochemistry, Genetics and Molecular Biology60.7%
  • Medicine28.9%
  • Immunology and Microbiology6.3%
  • Neuroscience1%
  • Agricultural and Biological Sciences1%
  • Engineering0.4%
  • その他1.7%

トピック

  • Epigenetics and DNA Methylation7%
  • Acute Myeloid Leukemia Research4.3%
  • Histone Deacetylase Inhibitors Research3.7%
  • Protein Degradation and Inhibitors3%
  • RNA modifications and cancer2.9%
  • MicroRNA in disease regulation2.8%
  • その他76.3%

共著者

全論文

検索で開く
  1. Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling

    著者: Laura A. Sena, Sha Li, Amit Jairaman, Murali Prakriya, Teresa Ezponda, David A. Hildeman, Chyung‐Ru Wang, Paul T. Schumacker, Jonathan D. Licht, Harris Perlman, Paul Bryce, Navdeep S. Chandel - Immunity 2013 被引用: 1,300

  2. Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

    著者: María E. Figueroa, Omar Abdel‐Wahab, Chao Lü, Patrick S. Ward, Jay Patel, Alan H. Shih, Yushan Li, Neha Bhagwat, Aparna Vasanthakumar, Hugo F. Fernández, Martin S. Tallman, Zhuoxin Sun, Kristy Wolniak, Justine Peeters, Wei Liu, Sung Choe, Valeria R. Fantin, Elisabeth Paietta, Bob Löwenberg, Jonathan D. Licht, Lucy A. Godley, Ruud Delwel, Peter J.M. Valk, Craig B. Thompson, Ross L. Levine, Ari Melnick - Cancer Cell 2010 被引用: 2,737

  3. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

    著者: Thomas Thum, Carina Gross, Jan Fiedler, Thomas Fischer, Stephan Kissler, Markus Bussen, Paolo Galuppo, Steffen Just, Wolfgang Rottbauer, Stefan Frantz, M. Castoldi, Jürgen Soutschek, Victor Koteliansky, Andreas Rosenwald, M. Albert Basson, Jonathan D. Licht, John T. R. Pena, Sara H. Rouhanifard, Martina U. Muckenthaler, Thomas Tuschl, Gail R. Martin, Johann Bauersachs, Stefan Engelhardt - Nature 2008 被引用: 2,357

  4. Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture

    著者: Nevin Yusufova, Andreas Kloetgen, Matt Teater, Adewola Osunsade, Jeannie M. Camarillo, Christopher R. Chin, Ashley S. Doane, Bryan J. Venters, Stephanie Portillo‐Ledesma, Joseph Conway, Jude M. Phillip, Olivier Elemento, David W. Scott, Wendy Béguelin, Jonathan D. Licht, Neil L. Kelleher, Louis M. Staudt, Arthur I. Skoultchi, Michael‐Christopher Keogh, Effie Apostolou, Christopher E. Mason, Marcin Imieliński, Tamar Schlick, Yael David, Aristotelis Tsirigos, C. David Allis, Alexey A. Soshnev, Ethel Cesarman, Ari Melnick - Nature 2020 被引用: 265

  5. EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation

    著者: Wendy Béguelin, Relja Popovic, Matt Teater, Yanwen Jiang, Karen Bunting, Monica W. Rosen, Hao Shen, Shao Ning Yang, Ling Wang, Teresa Ezponda, Eva Martínez-García, Haikuo Zhang, Yupeng Zheng, Sharad K. Verma, Michael T. McCabe, Heidi M. Ott, Glenn S. Van Aller, Ryan G. Kruger, Yan Liu, Charles F. McHugh, David W. Scott, Young Rock Chung, Neil L. Kelleher, Rita Shaknovich, Caretha L. Creasy, Randy D. Gascoyne, Kwok‐Kin Wong, Leandro Cerchietti, Ross L. Levine, Omar Abdel‐Wahab, Jonathan D. Licht, Olivier Elemento, Ari Melnick - Cancer Cell 2013 被引用: 841

  6. Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator

    著者: Jung Kim, Yongik Lee, Xiaodong Lü, Bing Song, Ka-wing Fong, Qi Cao, Jonathan D. Licht, Jonathan C. Zhao, Jindan Yu - Cell Reports 2018 被引用: 310

  7. Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition

    著者: Simon J. Hogg, Olga Motorna, Leonie A. Cluse, Timothy M. Johanson, Hannah D. Coughlan, Ramya Raviram, Robert M. Myers, Matteo Costacurta, Izabela Todorovski, Lizzy Pijpers, Stefan Bjelosevic, Tobias Williams, Shannon N. Huskins, Conor J. Kearney, Jennifer R. Devlin, Zheng Fan, Jafar S. Jabbari, Ben P. Martin, Mohamed Fareh, Madison J. Kelly, Daphné Dupéré-Richer, Jarrod J. Sandow, Breon Feran, Deborah A. Knight, Tiffany Khong, Andrew Spencer, Simon J. Harrison, Gareth P. Gregory, Vihandha O. Wickramasinghe, Andrew I. Webb, Phillippa C. Taberlay, Kenneth D. Bromberg, Albert Lai, Anthony T. Papenfuss, Gordon K. Smyth, Rhys S. Allan, Jonathan D. Licht, Dan A. Landau, Omar Abdel‐Wahab, Jake Shortt, Stephin J. Vervoort, Ricky W. Johnstone - Molecular Cell 2021 被引用: 170

  8. Piperlongumine conjugates induce targeted protein degradation

    著者: Jing Pei, Yufeng Xiao, Xingui Liu, Wanyi Hu, Amin Sobh, Yaxia Yuan, Shuo Zhou, Nan Hua, Samuel G. Mackintosh, Xuan Zhang, Kari B. Basso, Manasi Kamat, Qingping Yang, Jonathan D. Licht, Guangrong Zheng, Daohong Zhou, Dongwen Lv - Cell chemical biology 2023 被引用: 71

  9. Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins

    著者: Ryosuke Shirasaki, Geoffrey M. Matthews, Sara Gandolfi, Ricardo De Matos Simoes, Dennis L. Buckley, Joseline Raja, Quinlan Sievers, Johanna B. Brüggenthies, Olga Dashevsky, Haley Poarch, Huihui Tang, Megan Bariteau, Michal Sheffer, Yiguo Hu, Sondra L. Downey-Kopyscinski, Paul J. Hengeveld, Brian Glassner, Eugen Dhimolea, Christopher J. Ott, Tinghu Zhang, Nicholas Kwiatkowski, Jacob P. Laubach, Robert Schlossman, Paul G. Richardson, Aedín C. Culhane, Richard W.J. Groen, Eric S. Fischer, Francisca Vázquez, Aviad Tsherniak, William C. Hahn, Joan Levy, Daniel Auclair, Jonathan D. Licht, Jonathan J. Keats, Lawrence Boise, Benjamin L. Ebert, James E. Bradner, Nathanael S. Gray, Constantine S. Mitsiades - Cell Reports 2021 被引用: 115

  10. The Proto-oncometabolite Fumarate Binds Glutathione to Amplify ROS-Dependent Signaling

    著者: Lucas B. Sullivan, Eva Martínez-García, Hien P. Nguyen, Andrew R. Mullen, Éric Dufour, Sunil Sudarshan, Jonathan D. Licht, Ralph J. DeBerardinis, Navdeep S. Chandel - Molecular Cell 2013 被引用: 305

  11. Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2

    著者: Ronan P. Hanley, David Y. Nie, John R. Tabor, Fengling Li, Amin Sobh, Chenxi Xu, Natalie K. Barker, David Dilworth, Taraneh Hajian, Elisa Gibson, Magdalena M. Szewczyk, Peter J. Brown, Dalia Baršytė-Lovejoy, Laura E. Herring, Gang Greg Wang, Jonathan D. Licht, Masoud Vedadi, C.H. Arrowsmith, Lindsey I. James - Journal of the American Chemical Society 2023 被引用: 62

  12. Targeting Epigenetics in Cancer

    著者: Richard L. Bennett, Jonathan D. Licht - The Annual Review of Pharmacology and Toxicology 2017 被引用: 255

  13. Recruitment of FBXO22 for targeted degradation of NSD2

    著者: Yan Nie, John R. Tabor, Jianping Li, Maria Kutera, Jonathan St‐Germain, Ronan P. Hanley, Esther Wolf, Ethan Paulаkonis, Tristan M. G. Kenney, Shili Duan, Suman Shrestha, Dominic D. G. Owens, Matthew E. R. Maitland, Ailing Pon, Magdalena M. Szewczyk, Anthony Joseph Lamberto, Michael Menes, Fengling Li, Linda Z. Penn, Dalia Baršytė-Lovejoy, Nicholas G. Brown, Anthony M. Barsotti, Andrew W. Stamford, Jon L. Collins, Derek J. Wilson, Brian Raught, Jonathan D. Licht, Lindsey I. James, C.H. Arrowsmith - Nature Chemical Biology 2024 被引用: 56

  14. The Role of Nuclear Receptor–Binding SET Domain Family Histone Lysine Methyltransferases in Cancer

    著者: Richard L. Bennett, Alok Swaroop, Catalina Troche, Jonathan D. Licht - Cold Spring Harbor Perspectives in Medicine 2017 被引用: 218

  15. A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer

    著者: Damiano Fantini, Alexander P. Glaser, Kalen Rimar, Yiduo Wang, Matthew J. Schipma, Nobish Varghese, Alfred Rademaker, Amir Behdad, Aparna Yellapa, Yanni Yu, Christie C. Sze, Lu Wang, Zibo Zhao, Susan E. Crawford, Deqing Hu, Jonathan D. Licht, Clayton K. Collings, Elizabeth T. Bartom, Dan Theodorescu, Ali Shilatifard, Joshua J. Meeks - Oncogene 2018 被引用: 197

  16. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

    著者: Marco Tartaglia, Charlotte M. Niemeyer, Alessandra Fragale, Xiaoling Song, Jochen Buechner, Andreas Jung, Karel Hählen, Henrik Hasle, Jonathan D. Licht, Bruce D. Gelb - Nature Genetics 2003 被引用: 1,039

  17. Histone Methyltransferase MMSET/NSD2 Alters EZH2 Binding and Reprograms the Myeloma Epigenome through Global and Focal Changes in H3K36 and H3K27 Methylation

    著者: Relja Popovic, Eva Martínez-García, Ευγενία Γιαννοπούλου, Quanwei Zhang, Qingyang Zhang, Teresa Ezponda, Mrinal Y. Shah, Yupeng Zheng, Christine Will, Eliza C. Small, Youjia Hua, Marinka Bulic, Yanwen Jiang, Matteo Carrara, Raffaele Calogero, William L. Kath, Neil L. Kelleher, Ji-Ping Wang, Olivier Elemento, Jonathan D. Licht - PLoS Genetics 2014 被引用: 239

  18. Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias

    著者: Ricardo De Matos Simoes, Ryosuke Shirasaki, Sondra L. Downey-Kopyscinski, Geoffrey M. Matthews, Benjamin G. Barwick, Vikas A. Gupta, Daphné Dupéré-Richer, Shizuka Yamano, Yiguo Hu, Michal Sheffer, Eugen Dhimolea, Olga Dashevsky, Sara Gandolfi, Kazuya Ishiguro, Robin M. Meyers, Jordan Bryan, Neekesh V. Dharia, Paul J. Hengeveld, Johanna B. Brüggenthies, Huihui Tang, Andrew J. Aguirre, Quinlan Sievers, Benjamin L. Ebert, Brian Glassner, Christopher J. Ott, James E. Bradner, Nicholas Kwiatkowski, Daniel Auclair, Joan Levy, Jonathan J. Keats, Richard W.J. Groen, Nathanael S. Gray, Aedín C. Culhane, James M. McFarland, Joshua M. Dempster, Jonathan D. Licht, Lawrence Boise, William C. Hahn, Francisca Vázquez, Aviad Tsherniak, Constantine S. Mitsiades - Nature Cancer 2023 被引用: 40

  19. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells

    著者: Eva Martínez-García, Relja Popovic, Dong Joon Min, Steve M. M. Sweet, Paul M. Thomas, Leonid Zamdborg, Aaron Heffner, Christine Will, Laurence Lamy, Louis M. Staudt, David Levens, Neil L. Kelleher, Jonathan D. Licht - Blood 2010 被引用: 357

  20. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial–mesenchymal transition and invasive properties of prostate cancer

    著者: Teresa Ezponda, Relja Popovic, Maitri Shah, Eva Martínez-García, Yupeng Zheng, D-J Min, Christine Will, Antonino Neri, Neil L. Kelleher, Jian Yu, Jonathan D. Licht - Oncogene 2012 被引用: 159

  21. Histone mutations in cancer

    著者: Kimberly N. Espinoza Pereira, Jixiu Shan, Jonathan D. Licht, Richard L. Bennett - Biochemical Society Transactions 2023 被引用: 34

  22. A Mutation in Histone H2B Represents a New Class of Oncogenic Driver

    著者: Richard L. Bennett, Aditya Bele, Eliza C. Small, Christine Will, Behnam Nabet, Jon A. Oyer, Xiaoxiao Huang, Rajarshi P. Ghosh, Adrian T. Grzybowski, Tao Yu, Qiao Zhang, Alberto Riva, Tanmay P. Lele, George C. Schatz, Neil L. Kelleher, Alexander J. Ruthenburg, Jan Liphardt, Jonathan D. Licht - Cancer Discovery 2019 被引用: 105

  23. Widespread microRNA degradation elements in target mRNAs can assist the encoded proteins

    著者: Lu Li, Peike Sheng, Tianqi Li, Christopher J. Fields, Nicholas M. Hiers, Yuzhi Wang, Jianping Li, Casey M. Guardia, Jonathan D. Licht, Mingyi Xie - Genes & Development 2021 被引用: 60

  24. UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition

    著者: Teresa Ezponda, Daphné Dupéré-Richer, Christine Will, Eliza C. Small, Nobish Varghese, Tej Patel, Behnam Nabet, Relja Popovic, Jon A. Oyer, Marinka Bulic, Yupeng Zheng, Xiaoxiao Huang, Mrinal Y. Shah, Sayantan Maji, Alberto Riva, Manuela Occhionorelli, Giovanni Tonon, Neil L. Kelleher, Jonathan J. Keats, Jonathan D. Licht - Cell Reports 2017 被引用: 135